Skip to main content
Caplight Logo









Robigo

Robigo

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.robigo.bio/

Last Round

Series A

Sep 17, 2026

Total Funding Raised

$12.67M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Robigo is a biotechnology company that develops precision microbial treatments to improve plant health and recover lost yields.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biopesticidessynthetic biologymicrobial crop protectionengineered microbesagtechbiologicalsprecision agriculturesustainable farmingcrop healthplant pathogenssmall business innovation researchSBIRbiotech R&Dgreen chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Robigo Comparables

Compare Robigo with similar companies based on industry and business-model similarity.

Robigo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ascribe Bio
82%
Aphea.Bio
81%
Micropep
80%

Robigo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 17, 2026
GrantSep 15, 2025
AcceleratorJan 9, 2025
SeedMay 4, 2023
GrantJun 1, 2022
Pre Seed
Nov 5, 2021

Key People

Founding team and executive leadership

Andee Wallace

Founder Chief Executive Officer

Founding Team

Robigo Investors

Notable investors and investment history

Robigo investors
InvestorRounds
SVG Ventures|THRIVEAccelerator, Series A
Good Growth CapitalSeed
Climate CapitalPre Seed
Supply Change CapitalSeed
First Star VenturesSeed, Pre Seed
Endeavor8Seed, Series A
Congruent VenturesSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 17, 2026

    Leads by Bayer, Congruent Ventures, and Endeavor8 participated.

  • Feb 1, 2026

    Named a Technology Pioneer for developing biopesticides with social impact.

Recent news

Latest coverage and updates

  • launchesSep 21, 2026

    Robigo launched engineered microbial biopesticides targeting fungal diseases in soybeans and specialty crops on Sep 17th '26.

  • receives_financingSep 21, 2026

    Robigo received financing of $1.25M in NSF Phase II SBIR funding on Sep 1st '25.

Robigo Filings

Explore SEC and related filing metadata, where available.

Robigo filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Robigo's valuation, stock price, and market status.

Is Robigo a public or private company?

Robigo is a private company.

What is the current stock price of Robigo?

Robigo is a private company with no public stock price. No recent secondary market data is available.

How much is Robigo worth (valuation)?

Valuation information for Robigo is not publicly available.

Can I buy Robigo stock?

Robigo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Robigo's last funding round?

Robigo's most recent funding round was Grant on September 15, 2025.

Who are the main investors in Robigo?

Key investors in Robigo include Congruent Ventures.

Will Robigo IPO soon?

No public IPO plans have been announced for Robigo.

How can I track Robigo secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Robigo's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range15
Year Founded2021
Last FundingSep 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?